期刊文献+

云南省两市区脊髓灰质炎灭活疫苗接种情况调查 被引量:1

Inoculation Situation of Inactivated Polio Vaccine in Two Urban Areas in Yunnan Province
下载PDF
导出
摘要 目的:分析云南省昆明市五华区及丽江市脊髓灰质炎疫苗(PV)接种情况及脊髓灰质炎灭活疫苗(IPV)在每个剂次中所占的比率及普及情况。方法:从两地疾病预防控制中心儿童免疫规划信息管理系统中收集2016年5月~2017年7月儿童PV接种数据,应用描述性流行病学方法进行分析。结果:2016年5月~2017年7月,五华区共接种PV 65 349剂,每一剂接种率均为99%以上,第1、2、3及4次剂IPV所占比率分别为86. 02%、33. 62%、26. 30%及20. 33%;丽江市共接种脊髓灰质炎疫苗21 962剂,每一剂次接种率均为99%以上,第1、2、3及4次剂IPV所占比率分别为39. 75%、7. 55%、8. 20%及0. 07%,使用IPV种类多为Sabin-IPV、Salk-IPV、DTa P-IPV/Hib,DTa P-IPV/Hib所占比率最高(62. 63%,χ~2=9 597. 6,P <0. 001);丽江市IPV相对单一,95%为免费Sabin-IPV,五华区IPV接种率明显高于丽江市(χ~2=22 614. 9,P <0. 001)。结论:昆明市五华区IPV接种率明显高于丽江市。 Objective:To investigate inoculation situation of the polio vaccine(PV)and the proportion of inactivated polio vaccine(IPV)in each dose in Wuhua District of Kunming City and Lijiang City,Yunnan Province.Methods:The PV and IPV vaccination data of children from May 2016 to July 2017 were collected from the information management system of the Children's Immunization Program of the two local disease prevention and control centers.The descriptive epidemiological methods were used for analyzing data.Results:There were 65 349 PV doses in Wuhua District,and the inoculation rate of each dose was over 99%,and the percentages of IPV in the first,second,third and fourth dose were 86.02.%,33.62%,26.30%and 20.33%,respectively.In Lijiang City,there were 21 962 PV doses in total,and the inoculation rate of each dose reached 99%or more,but the percentage of IPV in the first,second,third and fourth dose were 39.75%,7.55%,8.20%and 0.07%.In Wuhua District,the most commonly used IPV types are Sabin-IPV,Salk-IPV and DTaP-IPV/Hib,among them,DTaP-IPV/Hib reached 62.63%(χ^2=9 597.6,P<0.001).In Lijiang City,95%of IPV is free Sabin-IPV.IPV vaccination rate in Wuhua District is significantly higher than that in Lijiang City(χ^2=22 614.9,P<0.001).Conclusion:The IPV vaccination rate in Wuhua District of Kunming City is significantly higher than that in Lijiang City.
作者 蒋曦 朱文兵 王静 詹会莲 李慧 宋杰 董少忠 JIANG Xi;ZHU Wenbing;WANG Jing;ZHAN Huilian;LI Hui;SONG Jie;DONG Shaozhong(Institute of Medical Biology,Chinese Academy of Medical Science and Peking Union Medical College,Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases,Kunming 650118,Yunnan,China;Wuhua District Center For Disease Control and Prevention,Kunming 650118,Yunnan,China;Lijiang Center For Disease Control and Prevention,Lijiang,674100,Yunnan,China)
出处 《贵州医科大学学报》 CAS 2019年第3期297-301,共5页 Journal of Guizhou Medical University
基金 中国医学科学院医学与健康科技创新工程重大协同创新项目(2016-I2M-1-019)
关键词 脊髓灰质炎疫苗 脊髓灰质炎灭活疫苗 接种 云南 poliomyelitis vaccine inactivated poliovirus vaccine vaccination Yunan
  • 相关文献

参考文献1

二级参考文献10

  • 1WHO. Polio vaccines: WHO position paper, January 2014 [ J ]. WER, 2014, 89 (9) : 73-92.
  • 2Sutter RW el al. Poliovirus vaccine-live[Ml. In OW Plotkin SA, Vac- cines, 6th edition 2013. Philadelphia: Elsevier-Saunders, 598-645.
  • 3Kapusinszky B, Moln6r Z, Szomor KN, et al. Molecular character- ization of poliovirus isolates from children who contracted vaccine- associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary [J]. FEMS Immunol Med Microbial. 2010, 58(2) : 211-217.
  • 4Polio Global Eradication Initiative. Polio Eradication and Endgame Strategic Plan 2013-2018 [ EB/OLI. Available at http://www. Po- lioeradication, org/Portals/0/Document/Resources/StrategyWork/ Peesp_ ES EN A4. pdf. May8,2013.
  • 5Thompson KM, Pallansch MA, Duintjer Tebbens R J, Wassilak SGF, Cochi SL. Modeling population immunity to support efforts to end the transmission of live polioviruses [ Jl. Risk Anal,2013, 33: 647-663.
  • 6Duintjer Tebbens ILl, Thompson KM. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation [ J]. J Infect Dis. 2014, 210 Suppl 1: S485- S497.
  • 7Publication W. Polio vaccines and polio immunization in the pre-e- radication era : WHO position paper-recommendations [ J ]. Vac- cine, 2010, 28(43): 6943-6944.
  • 8胡丽楠.H市5家预防接种门诊脊髓灰质炎疫苗使用现况调查[D].北京:中国疾病预防控制中心,2014:20-22.
  • 9Anis E. Insidious reintroduction of wild poliovirus into Israel, 2013 [J]. EuroSurv. 2013, 18(38): pii=20586.
  • 10余文周,甫尔哈提.吾守尔,汪海波,严冬梅,宁静,祝双利,温宁,张勇,崔惠,董昌新,樊春祥,许文波,罗会明,李黎.新疆维吾尔自治区2011年输入脊髓灰质炎野病毒并引起局部传播的调查处置经验和教训[J].中国疫苗和免疫,2013,19(4):361-364. 被引量:30

共引文献5

同被引文献8

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部